Naloxone CAS: 465-65-6

CAS NO: 465-65-6
Naloxone
Chemical Name: Naloxone
Molecular Formula: C19H21NO4
Formula Weight: 327.37
CAS No.: 465-65-6
Description Review
Description

Naloxone CAS: 465-65-6 is a medication used to counteract the effects of opioid overdoses. It is also used in combination with opioids to reduce the risk of addiction and dependence. This medication is popularly known under brand name Narcan.

Chemical name: Naloxone is the generic name for a medication that is classified as an opioid antagonist. The official generic name is (5α)-17-allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one.

Molecular formula: The molecular formula for naloxone is C19H21NO4.

Formula weight: The formula weight for naloxone is 327.37 g/mol.

CAS No: The CAS registry number for naloxone is 465-65-6.

Top Ten Keywords and Synonyms:

  1. Opioid reversal
  2. Overdose rescue
  3. Narcan
  4. Opiate antidote
  5. Naloxone hydrochloride
  6. Opioid-blocking
  7. Opioid antagonist
  8. Life-saving
  9. Prescription drug
  10. Opioid addiction treatment

Health benefits: The primary benefit of naloxone is its ability to reverse the effects of opioids in the body, such as slowed breathing, unconsciousness, and potential death. It is a life-saving medication in emergencies, especially in patients who have overdosed on opioids. Studies have shown that the use of naloxone can significantly reduce the risk of death from opioid overdose, making it an essential tool in the treatment of opioid addiction.

Potential effects: Naloxone works by binding to the same opioid receptors in the brain as the opioid drugs. It blocks the opioids' effects and reverses the depression of the central nervous system, including respiration, heart rate, and blood pressure. After administering naloxone, the patient may experience withdrawal symptoms, which can include agitation, vomiting, and sweating.

Product mechanism: Naloxone works by rapidly binding to the same receptors as opioids, essentially booting the opioid off the receptor sites to prevent it from continuing to stimulate the receptor. Once naloxone attaches to the opioid receptor, it immediately reverses the respiratory depression caused by opioids, restoring breathing and oxygenation. Additionally, naloxone can reverse the effects of multiple opioids, including fentanyl, morphine, and heroin.

Safety: Naloxone has been deemed a safe medication when used as directed; it is non-addictive and does not have any known interactions with other medications. Because of its safety, naloxone is available without a prescription in many places for use in an emergency. Although naloxone overdoses are rare, they can occur when administered in large doses or given too quickly, causing nausea, rapid heartbeat, and high blood pressure.

Side effects: The side effects of naloxone are generally mild and short-lived, including increased heart rate, sweating, and agitation. Patients may also experience withdrawal symptoms, including irritability, tremors, muscle pain, nausea, vomiting, and diarrhea. However, these symptoms subside quickly and should not cause any lasting harm.

Dosing information: The dosage of naloxone may vary depending on the patient, the severity of the overdose, and the opioid used. Injectable naloxone is typically used for severe overdose, and a dose of 0.4-2mg may be administered intravenously, intramuscularly or subcutaneously.

Intranasal naloxone spray is commonly used for outpatient or community use, and doses may range from 1-4mg per spray

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code